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Abstract
Background: Persistent diarrhoea in children is a common problem in low and middle income
countries. To help target appropriate treatment for specific pathogens in the absence of diagnostic
tests, we systematically reviewed pathogens most commonly associated with persistent diarrhoea
in children.
Methods: We sought all descriptive studies of pathogens in the stool of children with diarrhoea
of over 14 days duration in low and middle income countries with a comprehensive search of the
MEDLINE, EMBASE, LILACS and WEB OF SCIENCE databases. We described the study designs
and populations, assessed the quality of the laboratory tests, and extracted and summarised data
on pathogens. For Escherichia coli, we calculated high and low prevalence estimates of all
enteropathic types combined. Results across studies were compared for geographical patterns.
Results: Nineteen studies were included. Some used episodes of diarrhoea as the unit of analysis,
others used children. The quality of reporting of laboratory procedures varied, and pathogens
(particularly E. coli types) were classified in different ways. As there were no apparent regional
differences in pathogen prevalence, we aggregated data between studies to give a guide to overall
prevalence. Enteropathic E. coli types were commonly found in children with persistent diarrhoea
(up to 63%). Various other organisms, including viruses, bacteria and parasites, were detected but
across all studies their prevalence was under 10%. However, these pathogens were also found in
similar frequencies in children without diarrhoea.
Conclusion: A number of pathogens are commonly associated with persistent diarrhoea in
children, but in children without diarrhoea the pathogens are found with similar frequencies. New
research with carefully selected controls and standardised laboratory investigations across
countries will help map causes and help explore effective options for presumptive treatment.
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The problem
In 2002, diarrhoea caused an estimated 13.2% of child
deaths worldwide[1], most of them in children under the
age of five in low and middle income countries[2]. In this
group of children, around 3% to 19% of acute diarrhoea
episodes become persistent[3], and some experts estimate
that up to 50% of diarrhoea deaths may be due to persist-
ent diarrhoea[1]. As the number of deaths from acute
diarrhoea reduces following the widespread use of oral
rehydration therapy, the contribution of persistent diar-
rhoea to overall diarrhoea mortality is increasing. In addi-
tion, persistent diarrhoea may adversely affect nutritional
status[4] and is often associated with malnutrition.
Children living in poor areas with poor hygiene and sani-
tation conditions and children with poor nutritional sta-
tus are most at risk of developing persistent diarrhoea[3].
As poor nutrition is both a risk factor and a consequence
of persistent diarrhoea, the two are very commonly asso-
ciated. Children with HIV/AIDS are at particular risk; at
initial presentation to hospital with HIV/AIDS, around
36–50% [5-7] of children have persistent diarrhoea. Dys-
entery and more severe diarrhoeal illnesses are more likely
to become persistent than milder episodes[3]. Previous
antibiotic use and irrational use of antibiotics are also
considered to be risks factors for persistent diarrhoea[3].
Definition and causes
The World Health Organization (WHO) defines diar-
rhoea as the passing of three or more loose stools (which
take the shape of the container) within a 24 hour period.
A new episode of diarrhoea can occur after two full days
without diarrhoea. Episodes of diarrhoea lasting for less
than 14 days are defined as acute, episodes lasting for
more than 14 days are defined as persistent.
The causes of persistent diarrhoea in populations are
poorly understood, and in individuals often unknown.
Some pathogens, such as Cryptosporidium, Giardia lamblia
and enteroaggregative Escherichia coli (EAggEC) are
thought to be associated with persistent diarrhoea in
some locations[3]. Children with persistent diarrhoea and
HIV infection may have different patterns of enteric path-
ogens than those without HIV[8]. Pathogens detected in
persistent diarrhoea are often not the same as those
detected in the original acute episode, suggesting that sec-
ondary infections may be important[9]. In addition, chil-
dren may be infected with more than one enteric
pathogen, making it difficult to identify which, if any, is
causing the illness, or may have no detectable enteric
pathogens. Persistent diarrhoea may also be associated
with bacterial overgrowth in the small bowel[10], and
with poor nutritional status[11]. In addition, the diar-
rhoea may be caused by multiple factors including micro-
nutrient deficiencies, milk or food intolerances, or
diseases of the bowel, as well as prior antibiotic ther-
apy[12].
When and how to treat
The current recommendations of the Integrated Manage-
ment of Childhood Illness programme[13] for treating
persistent diarrhoea is that children with bloody diar-
rhoea are treated with antibiotics for Shigella, or for Enta-
moeba histolytica where the organism is detected in the
stool; it is recommended that children with watery diar-
rhoea are not treated with antimicrobials; except where
Giardia lamblia is found.
Even when an enteric pathogen is detected in children
with persistent diarrhoea, it is not always clear that this is
the cause of the illness. In addition, health workers in low
and middle income countries often have limited access to
diagnostic facilities to analyse stool samples of children
with diarrhoea. In these situations, treatment needs to be
syndromic, based on symptoms and the most likely cause
of the symptoms; and may include replacement fluid and
electrolytes, nutritional rehabilitation and sometimes
drug treatment[12].
The use of antimicrobials presumptively needs to be
approached with caution, as this can lead to drug resist-
ance, and also to potential adverse reactions with some
micro-organisms: entero-haemorrhagic E. coli (EHEC)
may release toxins more readily when a person is treated
with certain types of antibiotic, potentially causing severe
illness[14].
Given the limited knowledge about the causes of persist-
ent diarrhoea, we carried out a systematic review of stud-
ies that have attempted to identify aetiological agents in
young children with this condition in low and middle
income countries. We hoped in particular to identify
whether any particular organisms were commonly associ-
ated with this condition, and if there were any geographic
patterns. Either could help guide treatment of this condi-
tion in the absence of diagnostic facilities. The objective of
this review was to summarise studies of pathogens
reported in children with persistent diarrhoea and, where
available, in appropriate comparison groups without diar-
rhoea; and to explore whether there are any patterns in the
findings by region.
Methods
Inclusion criteria
We searched for published descriptive studies that ana-
lysed routinely collected data, data collected as part of a
surveillance project or point survey data, and which pro-
vided data on pathogens detected in the stool of at least 30
children under the age of six years, living in a low or mid-Page 2 of 15
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14 days duration). In reports where the age range of par-
ticipants was not specifically stated, but it was apparent
that all or almost all participants were below the age of six,
these studies were included. Participants could be
recruited from any setting including the general commu-
nity, primary health care services, and hospital outpatient
and inpatient services. Studies could also include an
appropriate comparison group of children without diar-
rhoea.
Studies also including older children or adults, or diar-
rhoea lasting for less than 14 days, were included pro-
vided that data from observations specific to children
under the age of six with persistent diarrhoea could be
extracted. Studies presenting data on only one species of
pathogen were excluded.
Search strategy
The search strategy was developed in collaboration with
an information retrieval specialist (see below). The strat-
egy was amended where necessary to search the other
databases listed. No language restrictions were applied.
The reference lists of included studies were also scruti-
nised for additional relevant studies, and an informal
search was undertaken of 'Google Scholar' using the
search terms 'pathogens persistent diarrhoea'. The final
formal search was undertaken May 20, 2008.
Search strategy
Databases searched:
MEDLINE (1966 to date) via the OVID interface
EMBASE (1980 to date) via the OVID interface
LILACS database – Latin American and Caribbean Health
Sciences Literature (1982 to present) – via Virtual Health
Library interface
WEB OF SCIENCE (Science Citation Index Expanded –
1945 to present)
The following search strategy was used in MEDLINE:
1. persistent (diarrhoea OR diarrhea) ti, ab.
2. chronic (diarrhoea OR diarrhea) ti, ab.
3. watery (diarrhea OR diarrhea) ti, ab
4. (diarrheal disease*) OR (diarrhoeal disease*) ti, ab
6. 1 OR 2 OR 3 OR 4) NOT cancer NOT (inflammatory
bowel disease*) NOT (ulcerative colitis)
7. diarrhea, Infantile/classification OR diarrhea, infantile/
etiology OR diarrhea, infantile/microbiology OR
diarrhea, infantile/parasitology OR diarrhea, infantile/
pathology [MeSH]
8. 6 OR 7
9. child* OR infant* OR pediatr* ti, ab
10. 8 AND 9
11. case-control studies [MeSH] OR epidemiological stud-
ies [MeSH]
12. descript* OR surve* OR monitor* ti, ab
13. 11 OR 12
14. 10 AND 13, Limits:humans
Study selection
Two authors independently inspected titles and abstracts
identified by the literature search in order to identify
potentially relevant publications. All potentially relevant
publications identified by at least one reviewer were
obtained in full text format, with the exception, due to
time constraints, of reports not available within the
United Kingdom. One author then applied the inclusion
criteria to select which studies to include in the review,
consulting with another in cases of uncertainty. All publi-
cations were scrutinised for duplication of study results.
Data extraction
For each study report, two authors worked together to
extract information describing the characteristics of the
study and assess its quality, using a proforma as a guide.
The data items extracted are shown below.
Data extracted from included studies
Geographic location of the study, including relevant
socio-economic or environmental situation, and
WHO region
Start and end dates of the study, and duration
Age range of the participants, and any additional
inclusion criteria or local factors such as HIV infection
or malnutrition. Where the participants were recruited
from, for example, outpatient clinic, hospital ward,
community, and how they were sampled
Whether or not the study also had a comparison group
without diarrhoea, how this group were selected and
whether and how they were matched to the diarrhoea
groupPage 3 of 15
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comparison group with no diarrhoea
Unit of analysis; whether data was presented by chil-
dren or episodes
Types of enteric pathogen tested for in each group
(persistent diarrhoea and comparison group without
diarrhoea)*
Number of children (or episodes) tested for each path-
ogen*
Number or percentage of children, episodes or sam-
ples where each pathogen was detected*
Number or percentage of children, episodes or sam-
ples with any detected enteric pathogen*
*One author extracted this data.
We extracted data on selected pathogens only, which we
identified as important potential causes of diarrhoea in
terms of both prevalence and potential to cause disease.
The list of pathogens for which we intended to extracted
data, where available, is shown in Table 1. We extracted,
where available, data on 'any pathogen' only where stud-
ies tested for a reasonably comprehensive range of patho-
gens. Where any organisms presented in a study paper
were excluded from our analysis, we did not use data pre-
sented on 'any pathogen' from that study.
For E. coli, we combined all enteropathic types (any which
have the capacity to cause enteric illnesses), with the
exception of the entero-haemorrhagic type (EHEC), into
one category, because different studies classified E. coli
very diversely, making it impossible to compare types
across studies. E. coli of an unspecified type, or classed as
'untypable' was excluded from the analysis because it was
not possible to assess whether it was enteropathic. E. coli
described by the authors as diff. E. coli, EAEC-D, EAEC
(diffuse) or E. coli showing diffuse Hep-2 adherence were
also excluded due to uncertainty about whether or not
they are pathogenic. EHEC was kept separate where possi-
ble due to its different behaviour when exposed to antibi-
otic drugs. For each study a note was made of the E. coli
types tested for, as described in the study.
Where it was not clear in a report whether some individu-
als may have tested positive for more than one type of E.
coli, we calculated high and low estimates of overall enter-
opathic E. coli frequency, using the largest E. coli category
as a conservative estimate and all E. coli categories added
together as a high estimate, adjusted where appropriate
using any additional information presented in the report
(for example, number of participants with any pathogens
detected, number with more than one pathogen
detected).
We planned to also extract data for any subgroups pre-
sented in the reports (for example by age or HIV status),
but no reports presented data for subgroups.
One author also extracted data to describe the quality of
reporting of the laboratory procedures used for the study,
and whether any of the pathogens were tested for antimi-
crobial sensitivity. The data items extracted are shown in
Table 2.
Data analysis
For each relevant reported pathogen in each study, we
extracted or calculated the number and percentage of chil-
dren, in both the persistent diarrhoea group and compar-
ison group without diarrhoea, with the pathogen detected
in the stool, based on the number of cases or individuals
tested and the number found positive. We also calculated
the standard deviation and the 95% confidence intervals
around the percentage.
Studies were grouped by the WHO Region of the study
population. For each region, and for all the studies
together, we noted or calculated the following parameters
for each pathogen and for any pathogen in combined
groups with persistent diarrhoea:
Number of studies where the pathogen was tested for
and results presented
Total number of participants or episodes where the
pathogen was tested for and results presented
Table 1: List of pathogens for which data was extracted
Viruses Bacteria Parasites
Rotavirus Campylobacter Giardia lamblia
Enteric adenovirus Shigella Crytosporidium
Astrovirus Salmonella Entamoeba histolytica
Norovirus Vibrio cholera Microsporidia
Enteropathic E coli (excluding EHEC) Isospora
Entero haemorrhagic E. coli (EHEC) CyclosporaPage 4 of 15
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ies of children or episodes where the pathogen was
detected
The median percentage across studies of children or
episodes where the pathogen was detected
Mean percentage across studies (weighted by study
sample size) of children or episodes where each path-
ogen was detected
For the comparison groups without diarrhoea we calcu-
lated similar summary statistics. However, in order to
make the mean percentage across the studies comparable
with that for the persistent diarrhoea group, we weighted
the contribution of each study according to the size of the
group with persistent diarrhoea, rather than the group
without diarrhoea. We did not calculate confidence inter-
vals for statistics derived from combined studies.
We do not present any data based on a combined number
of diarrhoea cases or comparisons of less than 30.
Results
Selection of studies
The initial search returned 1,853 references, from which
we selected 102 for full text retrieval; of these we were able
to retrieve 98; four were not available within the United
Table 2: Assessment of laboratory procedures
Laboratory processes: Samples: Were there any methods or timings described for collecting, storing and transporting stool 
samples?
Parasite detection: Were any methods described or referenced for the detection of parasites, other than 
the word 'microscopy'? (e.g. stain, magnification)?
Bacterial Culture: Were any methods described or referenced for the culture of bacteria, other than the 
word 'culture'? (e.g. media, temperature)
Bacteria identification: Were any methods described or referenced for the identification of cultured 
bacteria?
Virus detection: Were any methods described for the identification of viruses? 
(the name of the test was sufficient)
Quality control Were methods described for testing and controlling the quality of the laboratory tests used in the study?
Antimicrobial susceptibility testing Which of the pathogens detected in the study, if any, were tested for antimicrobial susceptibility?
Table 3: Reasons for exclusion of reports identified in the initial screening process as potentially relevant
Reason for exclusion Number of Reports
Diarrhoea status of participants
Included children with acute diarrhoea only 9
Wrong definition of persistent diarrhoea 2
Asymptomatic children only 1
Included all children in a community, whether or not they had diarrhoea 2
No separate analysis for cases of acute and persistent diarrhoea 41
Other participant characteristics
Participants were of the wrong age range 8
Participants resided in a high income country 3
Study design factors
Less than 30 participants 5
Faecal samples taken in the acute stage (before day 14) of the persistent episode 5
Tested for one organism only 4
Sampled only children who had been in close contact with Shigella dysentery 1
Reviewed hospital records only for children found positive for enteric pathogens 1
Not relevant
No data on frequency of pathogens presented 5Page 5 of 15
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time and resources. From these 98 reports we selected 14
studies for inclusion in the review. Table 3 lists the reasons
for exclusions of reports not included, and the number in
each category. We found reports of a further three relevant
studies through the reference lists of included studies,
another two through a different search undertaken for
another, related review, and three through an informal
search of 'Google Scholar'. We included a total of 20
reports describing 19 studies[4,15-33]. Two reports were
from the same surveillance project but presented data on
different pathogens[15,16], and also included children of
a slightly different age range.
Characteristics of included studies
Details of the characteristics of the individual studies
included in the review are presented in Tables 4 and 5
(link). Table 4 shows the characteristics of all the included
studies, in terms of the groups with persistent diarrhoea,
and Table 5 shows only the eight studies with a compari-
son group without diarrhoea[4,17-20,23,27,28,30], in
terms of the comparison group. One paper[32] did
present findings for a comparison group, but this group
was excluded from the analysis because it only included
15 individuals. Two papers based on the same data set are
described separately as they present data on a slightly dif-
ferent age group[15,16]. Within each table, the studies are
arranged by WHO region where they were carried out.
Each study is named according to the country where it was
conducted and the year of publication. A summary of the
information presented in Tables 4 and 5 is presented
below.
Locations and settings
Ten studies were conducted in the South-East Asia region;
four in Bangladesh[15-18,32] and six in India [19-24].
Five were conducted in the Americas, including three in
Brazil[4,27,30], one in Guatemala[28] and one in Mex-
ico[29]. Two were conducted in the Western Pacific
region, one on the border between Thailand and Cambo-
dia[25], and one in Vietnam[26]. Two studies were con-
ducted in the African region, both in Zambia[31,33].
Some studies were conducted within particularly vulnera-
ble communities, including three in areas described as
urban slums or shantytowns[4,23,27], one in a rural
indigenous community[28] and one in a resettlement
camp for refugees[25].
Participants
The included studies all involved between 40 and 410
children with persistent diarrhoea; 11 studies had less
than 100 participants[4,19,20,24-30,33], seven had more
than 100 but less than 200 participants [17,18,21-
23,31,32], and one had more than 200 participants
[15,16].
Fourteen studies included children from birth to a specific
age; in one study it was two years[19], in six it was three
years[20,22,23,28,30], in one it was four years[4], in five
it was five years[15-17,21,25,27] and in one it was six
years[18]. Others included children aged one to 36
months[16], three to 24 months[32] one to five years[24],
and 15 months to five years[33]. Two did not state an age
range for inclusion, but presented the mean and median
participant ages, respectively 16.6 months[29], and 18
months[31]. There were no apparent patterns of age range
inclusion by region.
Five studies[19,20,28,31,32] (three in Southeast Asia, one
in the Americas, one in the African region) excluded chil-
dren with bloody diarrhoea, or included only those with
watery diarrhoea. Three included children with all types of
persistent diarrhoea, while the other studies did not
describe the type of diarrhoea included. One study in the
African region included only children with diarrhoea over
30 days in duration[33], one in the Americas excluded
those with diarrhoea that had persisted for longer than 18
days[28].
Five studies included only children with additional signs
and symptoms; two in Southeast Asia stated that the chil-
dren must have lost weight or failed to gain weight during
the episode[19,24], two (one in Southeast Asia, one in
Africa) that the children should have specific signs of
under nutrition [20,31], one in the Western Pacific speci-
fied that children should also have either a rectal temper-
ature of over 38°C, colic or vomiting[25]. One study in
the Americas excluded children with specific diagnoses
such as caeliacs disease or short bowel syndrome[29], one
in South East Asia excluded children with systemic infec-
tions[32] and another in Africa excluded children with
neurological diseases[31]. Two studies excluded children
who had recently received antibiotics [30,32].
Two studies; both from Africa, looked specifically at chil-
dren who were HIV positive, and presented data on HIV
positive and HIV negative individuals separately. The data
is not presented separately in this review, as in one study
only 24 individuals were HIV positive[33] and the other
reported no significant differences in pathogen frequency
between the HV positive and HIV negative groups[31].
Sources of participants
Six of the included studies employed active surveillance to
identify all cases of persistent diarrhoea within a specific
cohort of children in a defined community, including
three from South-East Asia[17,18,23] and three from thePage 6 of 15
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Table 4: Characteristics of included studies: groups with persistent diarrhoea
Study report Location Start Duration Participants Source of cases Sampling 
method
Number of 
cases
Unit of Analysis
Bangladesh 
1992a [16]
Matlab (rural) 1988
1 yr
< 5 yrs Active 
household 
surveillance
All cases 
identified
Varied by 
pathogen 
(68 – 184)
Episodes
Bangladesh 
1992b [17]
Mirzapur (rural) 1987
2 yrs
< 6 yrs Active 
household 
surveillance
All cases 
identified
Varied by 
pathogen 
(53 – 153)
Episodes
India 1989 [18] New Delhi 1984
1 yr
< 2 yrs, no blood 
in stool, weight 
loss
Hospital 
admissions
Consecutive 
cases
92 Children
India 1992 [19] New Delhi 1988
28 mths
< 3 yrs, no blood 
in stool, weight 
for height = 90% 
of standard
Hospital 
admissions
Not described 81 Children
India 1999 [22] Slum New Delhi Unclear
Unclear
< 3 yrs Active 
household 
surveillance
All cases 
identified
115 Episodes
Brazil 1990 [26] Urban slum, 
Fortaleza
1984
28 mths
< 5 yrs Active 
household 
surveillance
All cases 
identified
40 Episodes
Brazil 1995 [29] Fortaleza 1988
32 mths
< 3 yrs, no 
antibiotics in 
past 72 hrs
Hospital 
admissions
Not described 56 Children
Brazil 2000 [4] Shanty town 
Fortaleza
1989
45 mths
< 4 yrs Active 
household 
surveillance
All cases 
identified
88 Episodes
Bangladesh 
1988 [14]
Dhaka 1983
3 yrs
< 5 yrs Outpatient 
attendances
Systematic 
every 25th case
410 Children
Bangladesh 
1991 [15]
Dhaka 1983
3 yrs
1 mth to 3 yrs Outpatient 
attendances
Systematic 
every 25th case
Varied by 
pathogen 
(391–445)
Children
Bangladesh 
1998 [31]
Dhaka Unclear
3 yrs
3 mths to 2 yrs, 
no blood in 
stools, no 
antibiotics, anti-
diarrhoeals or 
systemic 
infection
Outpatient 
attendances
Not described 138 Children
India 1995a [20] Madras Unclear
Unclear
< 5 yrs Hospital 
admissions
Not described 100 Children
India 1995b 
[21]
Amritsar Unclear
Unclear
< 3 yrs Hospital 
admissions
Not described 150 Children
India 2001 [23] Varanasi 1998
15 mths
1 to 5 yrs, 
weight loss or 
failure to gain 
weight
Hospital 
admissions & 
outpatient 
attendances
Randomly 57 Children
Guatemala 
1992 [27]
Rural 
indigenous 
community
1988
20 mths
< 3 yrs, watery 
diarrhoea for 14 
to 18 days
Active 
household 
surveillance
All cases 
identified
49 Children
Mexico 2003 
[28]
Mexico City 1997
Unclear 
(24–36 mths)
mean age 16.6 
mths, no specific 
diagnosis
Hospital 
admissions
Not described 89 Children
Cambodia 1992 
[24]
Resettlement 
camp, Thailand 
Cambodia 
border
1989
6 mths
< 5 yrs, with 
temperature 
over 38°C, colic 
or vomiting
Outpatient 
attendances
Consecutive 
cases
79 Children
Vietnam 1992 
[25]
Hanoi 1988
1 yr
< 3 yrs Hospital 
admissions
Not described 83 Children
Zambia 1995 
[32]
Lusaka Unclear
9 mths
15 mths to 5 yrs; 
diarrhoea for at 
least 30 days
Hospital 
admissions
Consecutive 
cases every 
alternate day
90 Children
Zambia 2001 
[30]
Lusaka 1998
26 mths
Inpatient in 
nutrition ward, 
median 18 mths, 
no blood in stool
Hospital 
admissions
Consecutive 
cases
194 Children
BMC Infectious Diseases 2009, 9:88 http://www.biomedcentral.com/1471-2334/9/88Americas[4,27,28]. Three sampled children attending
hospital outpatient departments, including children who
were also subsequently admitted to the wards, two in
South-East Asia[15,16,32] and one in the Western
Pacific[25]. Nine sampled only children who were already
admitted to a hospital ward, four in South-East Asia [19-
22], two in the Americas[29,30], two in Africa[31,33] and
one in the Western Pacific[26]. One study in South-East
Asia included both inpatients and outpatients treated at a
hospital[24].
Sampling strategies
All six of the community cohort studies included all the
children identified with persistent diarrhoea over the
duration of the project. Four of the studies recruiting
patients at healthcare facilities also sampled all consecu-
tive eligible patients[19,25,31,33]. One study included a
random sample (method of randomisation not
stated)[24] and one used a systematic sampling method
(every 25th patient)[15,16]. Reports of the remaining stud-
ies did not describe their sampling methods.
Date of studies
Most of the included studies were conducted over ten
years ago, and none presented data collected after 2000.
Taking the mid-year of the data collection period as the
reference point, three collected data in 1985 or before
[15,16,19,27], eight collected data between 1986 and
1990 [4,17,18,20,25,26,28,30], and three collected data
between 1996 and 1999 [24,29,31]. Five study reports
[21-23,32,33] did not state the date of the data collection,
three were published 1995, one was published 1998, and
one was published in 1999. There did not appear to be
any pattern of date of study by WHO region.
Duration of studies
Most of the included studies collected data for a period of
one year or more. One collected data for six months[25],
and one over a period of nine months[33]. Six collected
data for periods of whole years: three for one year
[17,19,26], one for two years [18] and two for three
years[15,16,32]. Six collected data for other periods of
time, between one and four years. Three study reports did
not give any information about dates or durations of data
collection [21-23]. There did not appear to be any pattern
of duration of data collection period by WHO region.
Units of analyses
Five of the community cohort type studies used episodes
as the unit of analysis, with children in both the persistent
diarrhoea and comparison groups (where used) often
included in the analysis more than once. One of the stud-
ies recruiting children from a community surveillance
project was reporting baseline data for a clinical trial, and
therefore included individual children only once[28]. The
remaining studies presented data as for individual chil-
Table 5: Characteristics of included studies: comparison groups without diarrhoea
Study report Location Source of cases Number of cases Source of 
comparison group 
without diarrhoea
Matching of 
comparison group
Number of 
children without 
diarrhoea
Bangladesh 1992a 
[16]
Matlab (rural) Active household 
surveillance
Varied by 
pathogen 
(68 – 184)
Same community 
study cohort
Age and proximity 
of residence
Varied by 
pathogen 
(67 – 164)
Bangladesh 1992b 
[17]
Mirzapur (rural) Active household 
surveillance
Varied by 
pathogen 
(53 – 153)
Same community 
study cohort
Age and proximity 
of residence
Varied by 
pathogen 
(46 – 213)
India 1989 [18] New Delhi Hospital 
admissions
92 Other wards with 
non-gastro-
intestinal illnesses
Age and 
nutritional status
92
India 1992 [19] New Delhi Hospital 
admissions
81 Nutrition clinic 
with failure to 
thrive and weight 
for height = 90% 
of standard
Not matched 32
India 1999 [22] Slum of New Delhi Active household 
surveillance
115 Same community 
study cohort
Age, nutritional 
status and 
proximity of 
residence
115
Brazil 1990 [26] Urban slum, 
Fortaleza
Active household 
surveillance
40 Same community 
study cohort
Not matched 38
Brazil 1995 [29] Fortaleza Hospital 
admissions
56 Children on other 
wards
By age 42
Brazil 2000 [4] Shanty town, 
Fortaleza
Active household 
surveillance
88 Same community 
study cohort
By age and sex 443Page 8 of 15
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dren who presented to the facility more than once during
the study period.
Comparison groups without diarrhoea
Eight study reports presented pathogen frequency data on
an appropriate comparison group of children without
diarrhoea, five in south-East Asia[17-20,23] and three in
the Americas[4,27,30]. One study described a comparison
group but did not present any relevant data[21]. In six
studies, the comparison participants were matched to par-
ticipants with persistent diarrhoea using specific crite-
ria[4,17-19,23,30], in two the diarrhoea and comparison
groups were not matched[20,27]. Five of the studies with
comparison groups were community cohort studies that
recruited the comparison group from the same commu-
nity[4,17,18,23,27]. The other three studies were based at
health facilities and used a comparison group of children
attending or admitted to the hospital with illnesses other
than diarrhoea.
Quality of reporting for laboratory procedures
Table 6 gives a summary of the assessed quality of report-
ing of the laboratory procedures used in the study, plus an
indication of whether there was any mention of antimi-
crobial susceptibility testing of bacteria being carried out,
and whether quality control procedures were described.
The quality of reporting varied widely across studies in all
WHO regions, with one study describing none of the pro-
cedures[24], while two reported six out of seven[18,25].
Two trials tested only for parasites and used three out of
the three possible procedures on our checklist[23,33].
Only two studies reported testing bacterial isolates for
antimicrobial susceptibility[18,24,25], and two described
quality control procedures[23,33].
Potential pathogen prevalence
Table S1 in Additional file 1 (link) shows, for each study,
the percentage of cases testing positive for different path-
ogens in the stool, and associated 95% confidence limits,
in children with persistent diarrhoea, and where available,
children without diarrhoea. The estimated prevalence of
each pathogen tended to be very imprecise, due to small
sample sizes. For studies with comparison groups without
diarrhoea, there was no significant difference in preva-
lence of any pathogen between the two groups.
Under Table S1 in Additional file 1 we list the E. coli types
tested for in each study, using the category conventions
stated by authors. All of the studies included ETEC, most
Table 6: Laboratory Procedures described or referenced in the included study reports
Samples Parasite detection Bacterial culture Bacterial 
identification
Virus detection Quality control Antimicrobial 
susceptibility 
testing
Bangladesh 1988 
[14]
X X X X  X X
Bangladesh 1991 
[15]
 -    X X
Bangladesh 1992a 
[16]
    - X X
Bangladesh 1992b 
[17]
     X 
Bangladesh 1998 
[31]
     X X
India 1989 [18]      X X
India 1992 [19]  X   X X X
India 1995a [20] X X   - X X
India 1995b [21]     - X X
India 1999 [22]   - - -  -
India 2001 [23] X X X X - X X
Cambodia 1992 
[24]
     X 
Vietnam 1992 [25] X X X X  X X
Brazil 1990 [26]      X X
Brazil 1995 [27]      X X
Brazil 2000 [4]    X  X X
Guatemala 1992 
[29]
     X X
Mexico 2003 [28] X    - X X
Zambia 1995 [32]   - - -  -
Zambia 2001 [30] X  X X - X XPage 9 of 15
(page number not for citation purposes)
BMC Infectious Diseases 2009, 9:88 http://www.biomedcentral.com/1471-2334/9/88also included EPEC; others included AggEC or EIEC; two
studies included EHEC. In two studies[17,20], it was
uncertain whether one category of E. coli referred to EPEC
or EHEC; in these cases it was assumed to be EPEC. No
percentages were calculated for individual E. coli types as
different naming conventions would have made compar-
ison between studies impossible. Two different sets of E.
coli estimates are presented: those based on the upper esti-
mate of the range, and those based on the lower estimates.
Only two studies tested for isospora[31,33] and two tested
for enteric adenovirus[4,19]. One study tested for Norovi-
rus [4] but was excluded from the analysis because the
sample size was less than 30. No studies tested for Astrovi-
rus or Cyclospora. Two studies tested specifically for EHEC
and found no EHEC infections[4,19].
As the prevalence of individual organisms did not show
extreme variations between studies, we combined the data
across studies to provide an approximate indicator of
prevalence across studies.
Study findings combined by WHO region are shown in
Table S2 in Additional file 1. Table S2 in Additional file 1
shows the number of studies testing for each pathogen,
the combined number of persistent diarrhoea cases tested,
the weighted mean percentage across studies of cases test-
ing positive, and the range between studies. There were no
apparent differences by region, although there were some
differences between studies, for example, rotavirus was
detected in between 0% and 20% of children.
Figure 1 illustrates in chart form the weighted mean per-
centage across all studies of cases testing positive for each
pathogen included in the review. It is apparent that the
stool samples of children with persistent diarrhoea con-
tained a range of pathogens. With the exception of enter-
opathic E. coli types, each pathogen was found in less than
10% of children across studies; in the case of E. coli the
estimated range was between 25% and 33%. In studies
that tested for a reasonably comprehensive range of path-
ogens, 65% of cases had some kind of pathogen detected
in the stool, varying widely between studies from 36% to
88%.
For each pathogen in each region, a median percentage of
cases testing positive across the studies was also calcu-
Weighted mean percentage across all studies of cases testing positive for each pathogen included in the reviewFigure 1
Weighted mean percentage across all studies of cases testing positive for each pathogen included in the 
review.
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Table 7: Summary of studies with control group: number of participants testing positive for different pathogens by region
South-East Asia The Americas All
Studies Persistent diarrhoea No diarrhoea Studies Persistent diarrhoea No diarrhoea Studies Persistent diarrhoea No Diarrhoea
N Weighted
Mean
N Weighted
Mean
N Weighted
Mean
N Weighted
Mean
N Weighted
Mean
N Weighted
Mean
Viruses
Rotavirus 4 496 2% 501 1% 3 162 12% 162 7% 7 658 5% 663 3%
Enteric 
adenovirus
1 92 1% 92 2% 1 66 11% 82 0% 2 158 5% 174 1%
Bacteria
Campylobac
ter
4 489 8% 375 9% 2 96 0% 80 0% 6 585 6% 455 8%
Shigella 4 496 5% 501 3% 3 184 3% 520 2% 7 680 4% 1021 2%
Salmonella 3 326 6% 337 0% 3 184 0% 520 0% 6 510 4% 857 0%
Vibrio 
cholerae
2 317 1% 373 1% 1 88 0% 440 0% 3 405 0% 813 1%
*All 
Enteropathic
E coli – 
upper 
estimate
4 386 32% 329 27% 3 164 63% 75 38% 7 550 41% 604 30%
*All 
Enteropathic
E coli – 
lower 
estimate
4 386 26% 328 22% 3 164 41% 275 25% 7 550 31% 603 23%
EHEC 1 92 0% 92 0% 1 51 0% 51 0% 2 143 0% 143 0%
Parasites
Giardia 
lamblia
5 504 8% 540 7% 3 184 14% 522 7% 8 688 10% 1062 7%
Cryptospori
dium
2 232 1% 280 4% 3 167 16% 369 5% 0 399 7% 649 4%
Entamoeba 
histolytica
5 504 2% 541 4% 3 184 1% 522 1% 5 688 2% 1063 3%
At least one 
pathogen
1 92 73% 92 22% 2 112 76% 233 60% 3 204 75% 325 43%
BMC Infectious Diseases 2009, 9:88 http://www.biomedcentral.com/1471-2334/9/88lated. These are not presented, as in most cases they were
less than 5% (absolute difference) either side of the mean.
The only exception was the lower estimate for E. coli in the
Americas, where the mean was 35% and the median was
25%.
Comparative prevalence of potential pathogens
For studies with an appropriate comparison group, Table
7 shows the number of studies testing for each pathogen,
total sample size, and weighted mean percentage across
studies of cases and comparisons testing positive for each
pathogen, separated by WHO region. There were no stud-
ies with a comparison group from the Western Pacific
region.
Figure 2 illustrates in chart form the weighted mean per-
centages of cases tested that tested positive for different
pathogens within the persistent diarrhoea groups and
comparison groups without diarrhoea in all eight studies
with a comparison group. As described in the methods
section, the data from the comparison group in each study
was weighted according to the sample size of the group
with persistent diarrhoea.
It is apparent from Table 7 and Figure 2 that the frequency
of detection of any kind of enteric pathogen was higher in
children with persistent diarrhoea, but for individual
pathogens any differences were very small (although dif-
ferences between groups were larger in the Americas than
in other locations).
Discussion
We were able to identify, retrieve and assess papers
describing 19 studies, of which eight also presented data
for an appropriate comparison group without diarrhoea.
However, other relevant studies may have been pub-
lished, but missed by the search. Some of the included
studies had main purposes that were different from the
Weighted mean percentage of cases tested that tested positive for different pathogens in children with persistent diarrhoea and compariso s without diarrhoeaFigure 2
Weighted mean percentage of cases tested that tested positive for different pathogens in children with per-
sistent diarrhoea and comparisons without diarrhoea.Page 12 of 15
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example 'Endoscopic and histopathological evaluation of
pre-school children with chronic diarrhoea' and 'Oral
gentamicin is not effective treatment for persistent diar-
rhoea'. We identified two reports only through the search
process for another review, and three through an informal
search of 'Google Scholar'. We can therefore suppose that
not all published studies presenting relevant data are
indexed in such a way that even quite wide systematic
electronic searches, such as the one we performed, can
easily identify. In addition, we know of four studies that
may possibly be relevant but that we were unable to
obtain within the UK.
The included studies were conducted in a range of geo-
graphic locations, including South-East Asia, the Ameri-
cas, Western Pacific and African Regions, some in contexts
where children may have a particularly high risk for per-
sistent diarrhoea, including slum areas and a resettlement
camp for refugees. The two studies carried out in Africa
were both based within the same hospital in Zambia;
these were the only studies to specifically include children
who were HIV positive; the sample sizes were too small to
assess whether the patterns of enteric infection were differ-
ent in HIV positive and HIV negative children.
The included studies used a range of methods and set-
tings, including surveys of children attending clinics or
admitted to hospital, baseline data collection on children
recruited for a clinical trial and community surveillance
projects seeking to actively identify children with persist-
ent diarrhoea. The units of analyses also differed; some
studies included individual children only once, while
some included all separate cases, whether or not they were
identified in the same child.
This review can only give an approximate indication of
the actual frequency of different pathogens, for several
reasons. Most studies had small sample sizes, so estimates
from individual studies are imprecise, and different stud-
ies tested for different pathogens, therefore even when
study results were combined, the sample size for some
organisms was still small. Some of the pathogens that we
considered to be important were not tested for in any of
the studies. In the case of E. coli, evolving knowledge
meant that different classification systems were used in
different studies, making it impossible to combine data
on type of E. coli across studies. Some studies included
more types of E. coli than others, automatically leading to
higher estimated prevalences for all enteropathic E. coli
types combined. The reporting of microbiological proce-
dures was generally poor, so it is unknown whether opti-
mum testing methods were used. The majority of studies
were more than ten years old; the relative prevalence of
different pathogens in persistent diarrhoea may have
changed since that time, and tests for different pathogens
may have become more accurate. In addition, the dura-
tion of many studies was not a multiple of 12 months, so
the results could have been affected by seasonal varia-
tions. In regards to the comparison groups without diar-
rhoea, in some studies the children may not have been
typical of children without diarrhoea in the community,
as they were hospital inpatients.
We used simple weighted means to combine data; this
could have given undue weight to larger studies which
may not have had findings typical of the other studies.
However, we also calculated medians and found them
very similar to the means, suggesting that any such effect,
if present, was not large. We also combined data extracted
from studies using different methodologies, including
studies presenting data based on individuals and those
presenting data on episodes, where some individuals were
included more than once. This was a pragmatic decision
based on the fact that in some studies it was unknown
whether each case presented related to a different individ-
ual or not. The methodological difficulties may have been
important if this review were to claim to represent a 'typi-
cal' population of young children with persistent diar-
rhoea in a low or middle income country; however the
wide range of study dates, settings and inclusion criteria
does not allow this. Frequencies of different pathogens
could feasibly vary according to study setting, particularly
in community setting compared with a hospital setting,
where the severity of disease is likely to differ. We did not
consider it worthwhile to undertake separate analyses for
studies carried out in different settings, because the wide
range of other differences between studies meant that the
results of any such analyses would have been very difficult
to interpret.
Despite the limitations of the included studies, and the
methods used to combine their results, the findings are
useful, as they highlight the range of pathogens that may
be associated with persistent diarrhoea, the potential of
these pathogens to vary in frequency by time and place,
and the uncertainty within populations and individuals
that any particular organisms are causal in persistent diar-
rhoea.
In individual studies comparing children with persistent
diarrhoea and without diarrhoea, there were no signifi-
cant differences between the groups in the prevalence of
any individual enteric pathogen, and any differences were
small even when all the studies' results were combined. A
higher proportion of children with persistent diarrhoea
tested positive for any pathogen, but the frequency of
detection was also high in children without diarrhoea;
across studies that tested for a comprehensive range of
organisms, 65% of children with persistent diarrhoeaPage 13 of 15
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43% of children without diarrhoea. In every study, a pro-
portion of children with persistent diarrhoea did not test
positive for any enteric pathogen, although no study
included tests for all relevant micro-organisms.
Children with persistent diarrhoea and without diarrhoea
carried a wide range of enteric pathogens, including
viruses, bacteria and parasites, and the rates of each varied
considerably between studies, although there were no
apparent differences between WHO regions. The fre-
quency of most pathogens was low, tending to vary in
children with persistent diarrhoea from 0% or 1% to
between 3% and 20% between studies. E. coli was an
exception, being much more common, detected in
between 25% to 33% of cases across studies, 6% to 91%
between studies. This does not take into account the dif-
ferent classes of E. coli tested for in different studies.
Conclusion
There is no evidence that any particular pathogen or type
of pathogen is associated with persistent diarrhoea in chil-
dren under the age of six in low and middle income coun-
tries. There is therefore no evidence to justify routine
antimicrobial use for children with persistent diarrhoea of
unknown cause, in keeping with current guidelines. Even
in cases where diagnostic facilities are routinely available,
pathogens detected in children with persistent diarrhoea
may not be the cause of the illness.
The data currently available on the frequency of different
enteric pathogens found in the stools of children with per-
sistent diarrhoea and without diarrhoea is limited in its
applicability and generalisability, especially in the range
of pathogens being tested for and the locations of the
studies. Better quality data, gathered from a range of set-
tings in low and middle income countries throughout the
world (including locations where routine microbiological
testing is not usually available), and repeated at set time
points, could inform health staff in the region of the types
of pathogens they should be alert to, and also inform
future policy and practice, both locally and globally.
Further good quality studies are needed. The analysis of
already available data, for example from hospitals or clin-
ics where routine microbiological testing is used, might
also be useful. Studies should ideally run for at least one
year, and present data collected over periods of exactly 12
months, or multiples of 12 months, particularly in areas
with seasonal climates. Sample sizes should be large
enough to give reasonably precise estimates of pathogen
frequency, given the wide range of pathogens that may be
found, and the low frequency of some of them. Authors
should report the study design and microbiological meth-
ods in sufficient detail to enable their quality to be
assessed. The types of pathogens tested for in these studies
should be standardised as far as possible, while remaining
flexible to allow the inclusion of new or previously rare or
unsuspected pathogens. The classification of enteropathic
E. coli should also be standardised if possible, concentrat-
ing on clinically useful distinctions between the types.
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